An integrated, lifecycle-based approach supports consistent dose delivery, usability, and compliance for combination products.
ISO 11040 - Combination Product & Device Performance
Pre-filled syringe systems represent a complex integration of container closure, delivery device, and drug product. Their performance directly impacts dose accuracy, patient usability, and overall product safety.
Unlike traditional packaging, syringes function as both a primary container and a delivery system, requiring a dual focus on container integrity and device performance. Failures in functionality, whether related to plunger movement, break-loose force, or dose delivery, can compromise therapeutic efficacy and introduce significant regulatory risk.
Our testing programs are designed to evaluate syringe systems in alignment with ISO 11040 standards, ensuring that both the physical container and functional delivery characteristics meet performance expectations throughout the product lifecycle.
Syringe System Evaluation
ISO 11040 provides the framework for assessing pre-filled syringe systems, with emphasis on dimensional, mechanical, and functional performance.
Our work spans the full system, including:
- Glass or polymer syringe barrels
- Elastomeric plunger stoppers
- Tip closures (needle shield or Luer systems)
- Siliconization and lubrication systems
Rather than evaluating these components in isolation, we assess how they function together as an integrated delivery system. This includes understanding frictional behavior, sealing performance during actuation, and consistency of force profiles across populations of units.
Particular attention is given to force profile characterization, as this directly impacts user experience and device reliability. Variability in break-loose and glide forces is analyzed statistically to ensure consistent performance within defined acceptance criteria.
Key Functional Performance Areas
Functional syringe performance is governed by several interdependent factors that must be characterized and controlled.
Break-loose force represents the initial force required to initiate plunger movement and is highly sensitive to stopper properties and lubrication uniformity. Glide force defines the sustained force required during injection and must remain within a range that ensures both usability and controlled delivery.
Dose accuracy is evaluated under dynamic conditions, ensuring that the delivered volume matches intended specifications across the full actuation profile. This is particularly critical for high-value biologics and low-volume injectables where small deviations can be clinically significant.
Additional evaluations may include closure integrity under actuation stress, plunger deformation behavior, and resistance to leakage during and after delivery.
Integrated Lifecycle Approach
Syringe performance is not static, it evolves with manufacturing processes, storage conditions, and time. For this reason, testing strategies are designed with lifecycle integration from the outset.
During development, efforts focus on understanding how formulation, siliconization, and component selection influence performance. This phase establishes baseline behavior and identifies potential risks.
Process qualification activities then evaluate how manufacturing parameters, such as filling, stoppering, and siliconization methods, impact functional outcomes. Controlled studies are used to define acceptable operating ranges and ensure reproducibility.
Validation formalizes testing methods and acceptance criteria, ensuring that performance metrics are statistically justified and aligned with regulatory expectations.
In commercial use, performance monitoring becomes part of stability programs, with testing designed to detect shifts in functionality over time. This is particularly important for long-term storage, where changes in lubrication or material properties may alter force profiles or delivery characteristics.
All testing is conducted with direct alignment to ISO 11040 requirements for pre-filled syringes, ensuring that dimensional, mechanical, and functional attributes are appropriately evaluated.
In addition, our approach considers broader regulatory expectations for combination products, including FDA guidance on human factors and device performance where applicable. Supporting standards such as ISO 11608 may also be incorporated when syringe systems interface with delivery devices.
The result is a program that integrates device performance, container functionality, and regulatory defensibility into a single cohesive framework.
Why choose Intertek for pre-filled syringe testing?
- Deep analytical expertise across method development, validation, stability, extractables and leachables, elemental impurities, and QC testing
- cGMP-compliant, FDA-regulated laboratories with DEA Schedule I–V handling capabilities
- Specialized experience in pre-filled syringe systems, including break-loose and glide force testing, Instron-based functional testing, and ISO 11040 performance evaluation
- Data-driven, deterministic testing methods that deliver sensitive, reproducible, and regulator-defensible results
- End-to-end lifecycle support from development and process qualification through validation and commercial stability, aligned with FDA, ASTM, and global regulatory expectations
Related Solutions
-
Container Closure Integrity and Container Qualification Services
-
Extractables and Leachables Testing
Frequently Asked Questions (FAQs)
ISO 11040 is an international standard that defines requirements for pre-filled syringe systems, including dimensional, mechanical, and functional performance. It ensures syringes deliver accurate doses, maintain container integrity, and function reliably as both a drug container and delivery device.
Pre-filled syringe testing includes break-loose force, glide force, dose accuracy, container closure integrity, and leakage testing. These evaluations ensure consistent functionality, patient usability, and compliance with ISO 11040 requirements.
Break-loose force is the initial force required to start plunger movement, while glide force is the sustained force needed during injection. Both are critical to ensuring consistent delivery, usability, and device reliability.
Dose accuracy ensures the correct volume of drug is delivered during injection. Small deviations can impact therapeutic effectiveness, especially for biologics and low-volume injectables, making it a key safety and regulatory requirement.
Syringe testing aligned with ISO 11040, supported by standards such as ISO 11608 and FDA guidance, provides validated data to demonstrate product safety, performance, and compliance for combination products.
